Sun Pharmaceutical Industries Limited has officially announced an investor call to discuss its recent acquisition of Organon & Co. The session is scheduled for April 27, 2026, at 8:00 am IST via a live video conference. Senior management will lead the discussion, providing key updates and insights regarding the strategic integration of this new asset into the company’s global portfolio.
Strategic Investor Briefing
Sun Pharmaceutical Industries Limited is hosting a dedicated investor call today, April 27, 2026, to address the acquisition of Organon & Co. This session serves as a critical platform for the company’s senior leadership to engage with stakeholders and outline the implications of this expansion for the company’s future growth strategy and market positioning.
Meeting Details
The investor call is set to commence at 8:00 am IST and will be conducted through a video conference platform. Participants are required to register through the official meeting link to access the session. Attendees are advised to ensure their audio settings are configured correctly and to remain muted during the management presentation, unless specifically instructed otherwise.
Leadership and Contact Information
For those seeking further information or post-call clarifications, the company has designated specific contact points. Investors may reach out to Dr. Abhishek Sharma, while media inquiries should be directed to Gaurav Chugh. Both contacts are available to assist with professional queries regarding this corporate development.
Source: BSE
